Literature DB >> 2121627

High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.

E J Shpall1, D Clarke-Pearson, J T Soper, A Berchuck, R B Jones, R C Bast, M Ross, Y Lidor, K Vanacek, T Tyler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2121627     DOI： 10.1016/0090-8258(90)90079-z

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  4 in total

1.  Second-look laparotomies in ovarian cancer: a medical oncologist's perspective.

Authors:  M Markman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  Phase 1 trials of intensive antineoplastic therapy: a need for a critical reassessment of who should be treated.

Authors:  M Markman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 3.  High-dose therapy with stem cell support in solid tumors.

Authors:  G Spitzer; F R Dunphy; C E Bowers; D R Adkins
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

4.  Treatment strategy for recurrent and refractory epithelial ovarian cancer: efficacy of high-dose chemotherapy with hematopoietic stem cell transplantation.

Authors:  Toshinari Muramatsu; Takao Shinozuka; Takeshi Hirasawa; Hitomi Tsukada; Hironobu Maeda; Tsuyoshi Miyamoto; Masaru Murakami; Hiroshi Kajiwara; Masanori Yasuda; R Yoshiyuki Osamura; Mikio Mikami
Journal:  Acta Histochem Cytochem       Date:  2006-05-26       Impact factor: 1.938
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.